Free Trial

Traws Pharma (TRAW) Earnings Date, Estimates & Call Transcripts

Traws Pharma logo
$4.99
-0.05 (-0.99%)
(As of 11/1/2024 ET)

Traws Pharma Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 12Estimated
Actual EPS
(Aug. 15)
-$4.87 Missed By -$4.87

Traws Pharma announced Q2 2024 earnings on August 15, 2024, reporting an EPS of -$4.87. Quarterly revenue was reported to be $0.06 million. With a trailing EPS of -$138.50, Traws Pharma's earnings are expected to grow next year, from ($146.00) to ($33.75) per share.

TRAW Upcoming Earnings

Traws Pharma's next earnings date is estimated for Tuesday, November 12, 2024, based off prior year's reporting schedules.

Get Traws Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Traws Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TRAW Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TRAW Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Traws Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.24-$0.24-$0.24
Q2 20241-$0.25-$0.25-$0.25
Q3 20242-$0.25-$0.25-$0.25
Q4 20242-$0.28-$0.20-$0.24
FY 20246-$1.02-$0.94-$0.98
Q1 20251-$0.31-$0.31-$0.31
Q2 20251-$0.33-$0.33-$0.33
Q3 20251-$0.35-$0.35-$0.35
Q4 20251-$0.36-$0.36-$0.36
FY 20254($1.35)($1.35)($1.35)

Traws Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024
(Estimated)
------- 
8/15/2024Q2 2024--$4.87 -$4.87-$4.87-$0.06M
5/15/2024Q1 2024-$0.24-$0.24--$0.24$0.06M$0.06M
4/1/2024Q4 2023--$0.20 -$0.20-$0.20-$0.06M
11/14/2023Q3 2023-$0.26-$0.23+$0.03-$0.23$0.06M$0.06M
8/10/2023Q2 2023-$0.29-$0.20+$0.09-$0.20$0.06M$0.06M
5/15/2023Q1 2023-$0.27-$0.28 -$0.01-$0.28$0.06M$0.06M
3/16/2023Q4 2022-$0.27-$0.26+$0.01-$0.26$0.08M$0.06M
11/14/2022Q3 2022-$0.21-$0.26 -$0.05-$0.26$0.06M$0.06M

Traws Pharma Earnings - Frequently Asked Questions

Traws Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on TRAW's earnings history.

Traws Pharma (NASDAQ:TRAW) has a recorded annual revenue of $230,000.00.

Traws Pharma (NASDAQ:TRAW) has a recorded net income of -$18.95 million. TRAW has generated -$138.50 earnings per share over the last four quarters.

Traws Pharma's earnings are expected to grow from ($146.00) per share to ($33.75) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:TRAW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners